CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Beckerle Mary C Director | Sale 10b5-1 | −9,812 | $53.66 | $527K | 16,079 |
| 2026-06-01 | WYSZOMIERSKI JACK L Director | Sale 10b5-1 | −3,925 | $50.55 | $198K | 284,384 |
| 2026-06-01 | Eckhardt Sue Gail Director | Sale 10b5-1 | −9,812 | $50.14 | $492K | 16,079 |
| 2026-05-26 | Aftab Dana EVP, Research and Development | Sale | −43,451 | $50.35 | $2.2M | 594,741 |
| 2026-05-20 | Haley Patrick J. EVP, Commercial | Sale | −32,110 | $49.81 | $1.6M | 357,638 |
| 2026-05-18 | Senner Christopher J. EVP and CFO | Sale | −34,901 | $50.00 | $1.7M | 952,317 |
| 2026-05-18 | Hefti Brenda SVP and General Counsel | Sale 10b5-1 | −6,625 | $50.21 | $333K | 106,762 |
| 2026-05-07 | Beckerle Mary C Director | Sale | −7,712 | $48.45 | $374K | 17,524 |
| 2026-05-07 | Freire Maria C Director | Sale | −20,634 | $46.00 | $949K | 100,819 |
| 2026-05-07 | POSTE GEORGE Director | Sale | −60,000 | $45.71 | $2.7M | 118,832 |
| 2026-02-24 | Aftab Dana EVP, Research and Development | Sale | −47,918 | $44.50 | $2.1M | 616,106 |
| 2026-02-19 | Aftab Dana EVP, Research and Development | Sale | −29,873 | $44.35 | $1.3M | 664,024 |
| 2026-02-18 | WYSZOMIERSKI JACK L Director | Sale 10b5-1 | −99,574 | $44.01 | $4.4M | 279,942 |
| 2026-02-18 | Smith Julie Director | Sale | −44,087 | $44.50 | $2.0M | 20,590 |
| 2026-02-18 | Smith Julie Director | Sale | −20,030 | $44.30 | $887K | 20,590 |
| 2026-02-18 | Hefti Brenda SVP and General Counsel | Sale 10b5-1 | −18,669 | $44.01 | $822K | 96,512 |
| 2026-02-17 | Smith Julie Director | Sale | −42,422 | $43.33 | $1.8M | 20,590 |
| 2026-02-17 | Senner Christopher J. EVP and CFO | Sale | −30,617 | $43.67 | $1.3M | 976,092 |
| 2026-02-17 | Haley Patrick J. EVP, Commercial | Sale | −3,036 | $43.84 | $133K | 446,686 |
| 2026-02-17 | Haley Patrick J. EVP, Commercial | Sale | −64,778 | $43.50 | $2.8M | 381,908 |
Page 1 of 3 · 58 trades